• A Role of the Brain Stress Systems in the “Dark Side” of Addiction (PDF) / George F. Koob, PhD
• Stress and Addiction Relapse: Psychobiological Mechanisms and Clinical Implications (PDF) / Rajita Sinha, PhD
• Hormonal Responses to Acute and Chronic Stress: A Role for Comfort Food (PDF) / Mary Dallman, PhD
• Mechanisms of Food Craving and Drug Addiction: Similarities and Differences (PDF) / Dana M. Small, PhD
• Chronic Stress: Effects on Eating and Cell Aging (PDF) / Elissa Epel, PhD
• Smoking Impairs Recovery from Alcohol: New Evidence (PDF) / Timothy C. Durazzo, PhD
• The Endocannabinoid System and the Regulation of Pain and Emotion (PDF)/ Daniele Piomelli, PhD
• Cannabinoid CB1 Receptor Antagonists: The New Option in the Treatment of Obesity, Metabolic Syndrome and Addiction (PDF) / Daniela Cota, MD
• A Chronic Care Perspective (PDF) / A. Thomas McLellan, PhD
• Defining the Continuum (PDF) / Constance Weisner, DrPH, MSW
• DBT and the Art of Engagement (PDF) / Elisabeth P. Bellows, MD
• The Role of Public Health in Addiction Medicine (PDF) / Robert Brewer, MD
• Illicit Drug Use Among Adolescents (PDF) / Amy Khan, MD, MPH
• Community & School Based Interventions Update (PDF) / Jeffery Wilkins, MD
• Alcohol Markers (PDF) / Denise Greene, MD
• Provigil, Lunestra and Topamax (PDF) / Denise Greene, MD
• Connection Through Suffering (PDF) / Michael Kearney, MD
• Opioids and Pain Pathways (PDF) / Peggy Compton, RN, PhD
• Emerging Insights from Research Models of Pain and Addiction (PDF) / Christopher J. Evans, PhD

• Neurobiology of Alcohol Dependence and Stimulant Abuse: Implications for Treatment Strategies (PDF) / Jeffery Wilkins M.D.
• Co-Morbid Substance Abuse and Severe Mental Illness (PDF) / John Tsuang, MD
• Co-Morbid Substance Abuse and Depression or Anxiety Disorders (PDF) / Romana Markvitsa M.D
• ADHD and Substance Abuse (PDF) / Henrik Zakari M.D.
  

• Introduction to the day / Karen Miotto, MD
• Neuroanatomy / Jodie Trafton, PhD
• Clinical Assessment from a Pain Management Perspective / Bill McCarberg, MD
• Assessment of Psychological Factors in Treatment of Chronic Pain / John McKellar, PhD
• Fibromyalgia: When it Hurst All Over: A 2005 Update / Stuart Silverman, MD
• Back Pain: Update / Bill McCarberg, MD
• Headache: Update / Philip O’Carroll, MD

• Co-Occurring Addiction and Severe Mental Disorders / Richard Ries, MD
• Co-Occurring Addiction and Mild/Moderate Mental Disorders / Richard Ries, MD
• Genetics of Alcoholism and Addiction / Marc Schuckit, MD
• Linking Science and Treatment in Addiction Medicine / Sean Koon, MD
• 12-Step Programs / Garrett O’Connor, MD
• Benzodiazepines / Mel Pohl, MD
• Infectious Diseases / Diana Sylvestre, MD
• Treatment of Dual Diagnosis Patients / John Tsuang, MD
• Stimulants / Richard Rawson, PhD
• Neonatal and Women’s Issues / Carol Archie, MD
• The Family in Recovery / Sue Jackson, MS, MFT
• Medical Review Officer / David Smith, MD

Order Audio Tapes of 2004 Presentations

Addiction Medicine State of the Art 2003
October 8-11, 2003, Radisson-Miyako Hotel, San Francisco

• Opioids: Should Tolerance Affect our Management? -- Pamela Pierce Palmer, MD, PhD, Director, Pain Management Center, UCSF
• The Thin Edge of the Wedge: Acceptance, Change, and Behavior Therapy in the Treatment of Addiction -- Elisabeth Bellows, MD, Private Practice of Psychiatry, Menlo Park, CA
• The Impact of Research on the Care of Addicted Patients: A NIDA Update -- Nora Volkow, MD, Director, National Institute on Drug Abuse
• Looking for the Neural Basis of Motivation -- Howard Fields, MD, PhD, Director, Wheeler Center for the Neurobiology of Addiction, UCSF
• Is There a Common Neural Substrate for Analgesia and Reward? -- Robert W. Gear, DDS, PhD, Assistant Clinical Professor, Department of Oral and Maxillofacial Surgery, UCSF
• Forget it! The Role of Alpha-2 Agonists in Fear Conditioning -- M. Frances Davies, PhD, Research Associate and Director of Faculty Development, Stanford University VAPAHCS
• Medications Development for Treatment of Drug Abuse: A Path from Clinical Trial to Market -- Donald R. Wesson, MD, Consultant, CNS Medication Development; Chair ASAM Committee on Medications Development, Oakland, CA
• Advances in the Genetics of Addiction -- Raymond White, PhD, Director, Ernest Gallo Clinic & Research Center, UCSF
• Hot Topics in Neuroimaging Addictive Disorders -- Nora Volkow, MD, Director, National Institute on Drug Abuse
• Alcohol-Induced Brain Injury and its Reversal with Abstinence: Clinical Magnetic Resonance Studies -- Dieter J. Meyerhoff, Dr.rer.nat, Associate Professor of Radiology, UCSF; Senior Research Associate, VA Medical Center, SF
• Ibogaine Analogues: Drug Development for Addictive Disorders -- Stanley Glick, PhD, MD, Professor and Director, The Center for Neuropharmacology and Neuroscience, Albany Medical Center, Albany, NY
• Co-Occurring Disorders: Overview of Latest Research and Clinical Implications -- Douglas Ziedonis, MD, MPH, Director, Division of Addiction, Robert Wood Johnson Medical School, Piscataway, NJ
• Contingency Management of Disability Benefits for Severely Mentally Ill Persons with Substance Disorders -- Richard Ries, MD, Psychiatry, Dual Disorders Programs and Addiction Programs, Harborview Medical Center, Seattle, WA
• Bipolar Disorder and Substance Abuse: Impact and Treatment Implications-- Mark Frye, MD, Associate Professor of Psychiatry, David Geffen School of Medicine at UCLA; Director, UCLA, Bipolar Disorder Research Program, Los Angeles, CA
• Integrating 12-Step Spirituality, 21st Century Pharmacotherapy and Dual Diagnosis Concepts -- Garrett O’Connor, MD, Associate Clinical Professor of Psychiatry, UCLA; Consultant, Betty Ford Center, Rancho Mirage, CA
• Post-traumatic Stress Disorder in the Addicted: What We Know, What We Need to Know: An Interactive Workshop -- Elisa Triffleman, MD, Senior Research Scientist, The Public Health Institute, Oakland, CA; Research Affiliate, Yale University School of Medicine
• Integrating Dual Recovery Therapy and Medications for Co-Occurring Disorders -- Douglas Ziedonis, MD, MPH, Director, Division of Addiction, Robert Wood Johnson Medical School, Piscataway, NJ
• Dialectical Behavioral Therapy in the Treatment of Bulimia and Binge Eating Disorder: Research and Practical Applications -- Deborah Safer, MD, Associate Director of Residency Training Program in Psychiatry, Staff Psychiatrist and Research Scientist, Stanford University, Palo Alto
• Treatment Needs of Women with Co-Occurring Disorders -- Joan Zweben, PhD, Exec. Dir., 14th St. Clinic & East Bay Community Recovery Project, Oakland; Clinical Prof. of Psychiatry, UCS
• Why Are So Many Dually Disordered Patients So Over-Medicated and What Are the Implications of This? -- Richard Ries, MD, Prof. of Psychiatry Univ. of Washington Medical School, Director of Outpatient Psychiatry, Dual Disorders Programs and Addiction Programs, Harborview Medical Center, Seattle
• Culture and Infection: Understanding Risk-Taking Among Heroin Users in San Francisco -- Daniel H. Ciccarone, MD, MPH, Assistant Professor, Department of Family and Community Medicine, and Department of Anthropology, History and Social Medicine, UCSF